In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh MM Rahman, MB Islam, M Biswas, AHM Khurshid Alam BMC research notes 8, 1-9, 2015 | 663 | 2015 |
Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis M Biswas, S Rahaman, TK Biswas, Z Haque, B Ibrahim Intervirology 64 (1), 36-47, 2021 | 610 | 2021 |
Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review DN Roy, M Biswas, E Islam, MS Azam PloS one 17 (3), e0265496, 2022 | 185 | 2022 |
Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi City M Biswas, MN Roy, MIN Manik, MS Hossain, SMTA Tapu, ... BMC public health 14, 1-7, 2014 | 183 | 2014 |
Prescription antibiotics for outpatients in Bangladesh: a cross-sectional health survey conducted in three cities M Biswas, DN Roy, A Tajmim, SS Rajib, M Hossain, F Farzana, N Yasmen Annals of clinical microbiology and antimicrobials 13, 1-7, 2014 | 92 | 2014 |
Water‐soluble Fraction of Abelmoschus esculentus L Interacts with Glucose and Metformin Hydrochloride and Alters Their Absorption Kinetics after … H Khatun, A Rahman, M Biswas, AU Islam International Scholarly Research Notices 2011 (1), 260537, 2011 | 87 | 2011 |
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine C Kloypan, N Koomdee, P Satapornpong, T Tempark, M Biswas, ... Pharmaceuticals 14 (11), 1077, 2021 | 53 | 2021 |
Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome … M Biswas, MSK Kali, TK Biswas, B Ibrahim Platelets 32 (5), 591-600, 2021 | 31 | 2021 |
Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications M Biswas The Pharmacogenomics Journal 21 (2), 190-199, 2021 | 31 | 2021 |
Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies M Biswas, N Sawajan, T Rungrotmongkol, K Sanachai, M Ershadian, ... Frontiers in pharmacology 13, 835136, 2022 | 26 | 2022 |
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing … M Biswas, SK Kali Cardiovascular drugs and therapy, 1-13, 2021 | 25 | 2021 |
Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients … M Biswas, MSK Kali Scientific Reports 11 (1), 5012, 2021 | 25 | 2021 |
Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles … M Biswas, S Rahaman, TK Biswas, B Ibrahim International journal of clinical pharmacy 43, 1360-1369, 2021 | 23 | 2021 |
Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease … M Biswas, S Rahaman, TK Biswas, B Ibrahim Expert Opinion on Drug Safety 19 (12), 1605-1616, 2020 | 22 | 2020 |
Pharmacogenomics in Asians: differences and similarities with other human populations M Biswas, P Jinda, C Sukasem Expert Opinion on Drug Metabolism & Toxicology 19 (1), 27-41, 2023 | 21 | 2023 |
Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis M Biswas, M Ershadian, J Shobana, AH Nguyen, C Sukasem Clinical and Translational Science 15 (8), 1887-1905, 2022 | 21 | 2022 |
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing … M Biswas, C Sukasem, MS Khatun Kali, B Ibrahim Pharmacogenomics 23 (3), 207-220, 2022 | 19 | 2022 |
Cephalosporin-3G, highly prescribed antibiotic to outpatients in Rajshahi, Bangladesh: prescription errors, carelessness, irrational uses are the triggering causes of … AU Chouduri, M Biswas, MU Haque, MSI Arman, N Uddin, N Kona, ... Journal of Applied Pharmaceutical Science 8 (6), 105-112, 2018 | 18 | 2018 |
Medication errors in a private hospital of Bangladesh TR Paul, MA Rahman, M Biswas, M Rashid, MAU Islam Bangladesh Pharmaceutical Journal 17 (1), 32-37, 2014 | 16 | 2014 |
Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis C Atasilp, M Biswas, P Jinda, N Nuntharadthanaphong, J Rachanakul, ... Clinical and Translational Science 15 (7), 1613-1633, 2022 | 15 | 2022 |